Skip to main content
. 2019 Oct 30;10(12):2289–2299. doi: 10.1111/1759-7714.13226

Table 4.

Glutamine metabolism‐related markers in relation to clinicopathological characteristics and EGFR mutation status. Glutaminase GLS2 protein expression in EGFR wild‐type versus EGFR‐mutated non‐small cell lung cancer

EGFR wild‐type EGFR‐mutated P‐value
GLS2
<5% 51 (78.5%) 2 (40%) 0.025
5–20% 7 (10.8%) 0 (0%)
>20% 7 (10.8%) 3 (60%)

EGFR, epidermal growth factor receptor; GLS2, glutaminase 2.